Educational information
This video was recorded at the ESC in Paris, France, on September 2, 2019.
Faculty
Dr Michael Maeng of Aarhus University Hospital and Aarhus University.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Overview
ESC 2019 Long-term follow-up data of the DANAMI-2 trial showed that pPCI is the best strategy for STEMI patients compared to fibrinolysis, if transport to an invasive center is less than two hours.
Presenters
